CalciMedica
CALC
27 hedge funds and large institutions have $14.2M invested in CalciMedica in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.
430% more call options, than puts
Call options by funds: $233K | Put options by funds: $44K
4% less funds holding
Funds holding: 28 → 27 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
31% less capital invested
Capital invested by funds: $20.7M → $14.2M (-$6.46M)
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$138K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$49K |
| 3 |
Renaissance Technologies
New York
|
+$33.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.4K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$25.8K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$319K |
| 2 |
SC
Sculptor Capital
New York
|
-$240K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$158K |
| 4 |
Two Sigma Investments
New York
|
-$57.6K |
| 5 |
Two Sigma Advisers
New York
|
-$48K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Two Sigma Advisers
New York
| – | -$48K | -1,857 | Closed |
|
27
Simplex Trading
Chicago,
Illinois
| – | -$12.9K | -676 | Closed |
|
|
CG
28
Cutler Group
San Francisco,
California
| – | -$3.22K | -169 | -92% |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| – | -$3.01K | -158 | -92% |
|
30
Citigroup
New York
| – | +$38 | +2 | New |
|
CALC Hedge Fund Activity: Q1 2022 in Review
27 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q1 2022, worth a combined $14.2M — down 31% from $20.7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CALC and 4 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 6 added.
The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $138K. The largest seller was Morgan Stanley, cutting an estimated $319K.
- 27 institutional investors held CalciMedica (CALC) as of Q1 2022, down from 28 in Q4 2021.
- Funds reported $14.2M of CalciMedica stock for Q1 2022, down 31% quarter-over-quarter.
- 4 funds opened new CalciMedica positions in Q1 2022 and 5 closed out, a net change of -1 holder.
- The largest CalciMedica buyer in Q1 2022 was Bank of New York Mellon, an estimated $138K added.
- The largest CalciMedica seller in Q1 2022 was Morgan Stanley, an estimated $319K sold.
Based on aggregated 13F filings for Q1 2022.